• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Advanced Enzyme Technologies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19816.0
  • ISIN : INE837H01020
360.35 10 (2.75%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    352.00

  • Today’s High

    366.25

  • Open

    352.00

  • Perv Close

    350.70

  • 52W Low

    257.90

  • 52W High

    571.00

Key Indicators

  • P/E(TTM)

    39.37

  • Mar.Cap (₹Cr.)

    4,031.64

  • Div & Yield %

    1.44

  • Book Value(₹)

    56.25

  • Debt-Equity Ratio

    2.75

  • AGM Date

    01-Aug-2025

  • EPS

    9.15

  • P/E Ratio

    39.37

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    4,031.64

  • RONW (%)

    10.70

  • ROCE (%)

    14.53

Score Board

  • Equity (₹ in Cr.)

    22.38

  • BV (₹)

    56.30

  • Sales( ₹ in Cr.)

    351.41

  • NP (in Cr.)

    102.37

  • NP Var(%)

    -17.0

  • Div%

    260.0

  • CPS (₹)

    10.20

  • EPS (₹)

    9.10

  • Traded Value (₹ in Lakhs)

    4,030.52

  • 52 Week High

    571.00

  • 52 Week Low

    257.90

  • Price BSE

    360.0

  • Price NSE

    360.00

  • Market Capital( in Cr.)

    4,030.52

  • P/C Ratio

    35.40

  • P/E Ratio

    39.30

  • Price Vs.BV

    9.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 351.41 365.47 311.53 272.80 283.47 247.35
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 351.41 365.47 311.53 272.80 283.47 247.35
Other Income 61.49 58.81 9.81 9.08 6.82 9.00
Stock Adjustments 6.47 7.83 -1.48 13.52 -1.27 5.68
Total Income 419.37 432.11 319.86 295.40 289.02 262.03
EXPENDITURE :            
Raw Materials 148.80 139.56 121.43 112.72 95.03 94.44
Power and Fuel Cost 18.52 22.73 19.58 16.19 11.53 10.95
Employee Cost 56.04 49.39 41.42 39.32 34.23 32.61
Other Manufacturing Expenses 19.94 18.57 14.52 13.53 9.25 9.08
Selling and Administration Expenses 38.39 33.64 32.37 28.66 28.49 25.74
Miscellaneous Expenses 5.25 22.95 5.64 3.08 2.81 3.26
Employee Benefit Expenses 56.04 49.39 41.42 39.32 34.23 32.61
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 286.93 286.83 234.97 213.49 181.35 176.08
Operating Profit 132.44 145.28 84.89 81.90 107.67 85.96
Interest 0.51 0.39 0.33 0.27 0.24 1.29
Gross Profit 131.93 144.89 84.56 81.63 107.43 84.67
Depreciation 11.41 10.90 10.28 9.56 9.01 8.81
Profit Before Tax 120.52 133.99 74.28 72.07 98.42 75.86
Current Tax 16.89 26.95 18.25 18.02 24.84 19.39
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.22 -1.08 0.50 -0.46 2.57 -1.49
Reported Net Profit 102.42 108.12 55.53 54.51 71.01 57.96
Extraordinary Items 0.05 -15.13 -0.59 0.89 0.51 0.00
Adjusted Net Profit 102.37 123.25 56.12 53.62 70.50 57.96
Adjustment below Net Profit -0.34 -0.10 0.49 0.02 -0.03 -1.31
P & L Balance brought forward 469.61 417.50 372.66 328.19 263.91 213.96
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 57.03 55.91 11.18 10.06 6.70 6.70
P & L Balance carried down 514.66 469.61 417.50 372.66 328.19 263.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 260.00 255.00 50.00 50.00 45.00 30.00
Dividend Per Share(Rs) 5.20 5.10 1.00 1.00 0.90 0.60
Earnings Per Share-Unit Curr 9.15 9.67 4.97 4.88 6.36 5.19
Earnings Per Share(Adj)-Unit Curr 9.15 9.67 4.97 4.88 6.36 5.19
Book Value 56.25 51.91 46.98 42.97 38.97 33.17
Book Value(Adj)-Unit Curr 56.25 51.91 46.98 42.97 38.97 33.17

Shareholding Pattern

  • Promoter Group

    43.08%

  • Public Share Holding

    56.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 45,990,885 45,990,885.00 45,990,885 45,990,885
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 45,990,885 41.11 45,990,885 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,203,800 1.97 2,203,800 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,203,800 1.97 2,203,800 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 13,509,522 12.07 13,509,522 1
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,735,257 11.38 12,735,257 61
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 6,103,573 5.46 6,103,573 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,347,408 2.99 3,347,408 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 35,695,760 31.91 35,695,760 80
2] Non Institution
Bodies Corporate 1,564,294 1.40 1,564,294 347
Clearing Members 640 0.00 640 4
Directors of their Relatives 1,899,750 1.70 1,899,750 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,639,940 3.25 3,639,940 1,622
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 614,255 0.55 614,255 1,472
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,397,049 1.25 1,397,049 6
Individuals holding nominal share capital up to Rs. 1 lakh 17,535,163 15.67 17,323,163 64,026
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 552,701 0.49 552,701 2
Others 763,413 0.68 763,413 13
Sub Total 27,990,705 25.02 27,778,705 67,495
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 111,881,150 100.00 111,669,150 67,589

Company Background

Advanced Enzyme Technologies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Advanced Enzyme Technologies Ltd
  • BSE Code : 19816.0
  • ISIN : INE837H01020

  • Incorporation Year

    1989

  • Registered Office

    Sun Magnetica 5th Floor
    Nr LIC Serivce Road Louiswadi, Thane,
    Maharashtra-400604

  • Telephone

    91-22-41703200

  • FAX

    91-22-25835159

  • Chairman

    VASANT RATHI

  • Managing Director

  • Company Secretary

    Sanjay Basantani

  • Auditor

    MSKA & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Advanced Enzyme Technologies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Advanced Enzyme 360.25 412.90 351.41 39.37 19.91
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10